TMCI
Treace Medical Concepts, Inc.
NASDAQ · USHealthcareMedical - Devices
$4.23-1.63%
Price as of Jul 20, 2026
TMCI valuation
Treace Medical Concepts, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.23x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.55x
- Price / sales
- 1.32x
- Price / cash flow
- -21.22x
Enterprise value
- Enterprise value
- $236.1M
- EV / sales
- 1.14x
- EV / EBITDA
- -5.10x
- EV / EBIT
- -4.24x
- Market cap
- $274.4M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.